Modern Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$548K Buy
11,420
+3,784
+50% +$163K 0.01% 690
2026
Q1
$279K Sell
7,636
-436
-5% -$20.7K ﹤0.01% 739
2025
Q4
$411K Hold
8,072
0.01% 587
2025
Q3
$448K Buy
8,072
+1,298
+19% +$76K 0.01% 534
2025
Q2
$468K Buy
6,774
+806
+14% +$54.8K 0.01% 493
2025
Q1
$414K Buy
+5,968
New +$493K 0.01% 457
2024
Q4
Sell
-1,787
Closed -$213K 595
2024
Q3
$213K Buy
1,787
+147
+9% +$19.6K 0.01% 408
2024
Q2
$234K Sell
1,640
-381
-19% -$50.5K 0.02% 359
2024
Q1
$259K Buy
+2,021
New +$241K 0.02% 263

Other funds holding NVO

Modern Wealth Management's NVO Position: Q2 2026 in Review

Modern Wealth Management increased its Novo Nordisk (NVO) stake by 50% in Q2 2026, buying an estimated $163K and bringing the position to 11,420 shares worth $548K. The position accounts for 0.01% of the portfolio, ranked #690.

Modern Wealth Management first reported a position in NVO in Q1 2024 and has held it in 9 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Modern Wealth Management held 11,420 shares of Novo Nordisk worth $548K as of Q2 2026.
  • Modern Wealth Management bought 3,784 Novo Nordisk shares in Q2 2026, an estimated $163K.
  • Novo Nordisk made up 0.01% of Modern Wealth Management's portfolio in Q2 2026, its #690 holding.
  • Modern Wealth Management first reported a position in Novo Nordisk in Q1 2024 and has held it in 9 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Modern Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.